The Centers for Medicare & Medicaid Services (CMS) has outlined how it plans to identify 340B claims to remove when [...] …
Blog Posts
The rates 340B pediatric hospitals negotiate with payers for new pediatric oncology drugs often exceed a medication’s average sale price, [...] …
Drugmaker Sumitomo Pharma America (SMPA) is partially or fully exempting providers in five additional states from its 340B contract pharmacy [...] …
Breaking News
Missouri Become Eighth State to Enact 340B Contract Pharmacy Access Law After Governor Declines to Act on Bill
Missouri will become the eighth state to prohibit drug manufacturer 340B contract pharmacy restrictions after Gov. Mike Parson (R) announced [...] …
The upcoming U.S. presidential and congressional elections will significantly alter the direction of 340B and broader healthcare policy, a 340B [...] …
More than sixty 340B advocates braved an excessive heat warning in the nation’s capital yesterday afternoon for the third annual [...] …
SPONSORED CONTENT
While federal laws and regulations set the foundation for 340B compliance, state-level laws introduce an additional layer of complexity. Covered entities (CEs) must be vigilant in understanding how these state laws can impact their operations to avoid potential compliance pitfalls. We have outlined a few
…
As hospital advocates prepared to begin their annual summer visits to Capitol Hill this week, five congressional Democrats signed on [...] …
An anti-government waste group with ties to the drug industry is urging lawmakers to “stop the feeding frenzy” in the [...] …
Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...] …